Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
Gusty winds and torrential rain in any thunderstorms. Most at risk across the southern half of the UK.
Donald Trump said on Saturday that conversations about a potential summit were ‘going along very well’.
Mercedes boss Toto Wolff has suggested the FIA have thrown his team 'under the bus' after deciding not to penalise Ferrari.